Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients

ClinicalTrials.gov ID: NCT00007436

Public ClinicalTrials.gov record NCT00007436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, Multicenter Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety of tenofovir disoproxil fumarate (tenofovir DF) in combination with other anti-HIV drugs in patients who have participated in other tenofovir DF studies (GS-98-902 or GS-99-907), are able to tolerate the drug at different doses, and may benefit from having tenofovir DF treatment.

Study identification

NCT ID
NCT00007436
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
0 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
East Bay AIDS Ctr Berkeley California 94705 —
Tower ID Med Associates Los Angeles California 90048 —
Pacific Horizons Med Group San Francisco California 94115 —
Harbor - UCLA Med Ctr Torrance California 90502 —
Univ of Colorado / Health Science Ctr Denver Colorado 80262 —
Physicans Home Service Washington D.C. District of Columbia 20037 —
Steinhart Medical Associates Miami Florida 33133 —
Dr Gerald Pierone Jr Vero Beach Florida 32960 —
Northstar Med Clinic Chicago Illinois 60657 —
CRI New England Brookline Massachusetts 02146 —
Univ of Minnesota Minneapolis Minnesota 55455 —
Univ of Rochester Med Ctr Rochester New York 14642 —
Research & Education Group Portland Oregon 97209 —
Hershey Med Ctr Hershey Pennsylvania 17033 —
Anderson Clinical Research Pittsburgh Pennsylvania 15221 —
Roger Williams Med Ctr Providence Rhode Island 02908 —
Southwest Infectious Diseases Associates Dallas Texas 75246 —
Thomas Street Clinic Houston Texas 77009 —
Dr Philip C Craven Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00007436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00007436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →